The Role of the Vascular Surgeon in Oncologic Surgery of Abdominal and Pelvic Retroperitoneal Masses

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 29, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the role of vascular surgeons in the surgical treatment of retroperitoneal tumors, which are abnormal growths found in the area behind the abdominal organs. These tumors can be benign (non-cancerous) or malignant (cancerous), with the majority being malignant. The goal of the surgery is to remove these tumors completely while minimizing risks and complications. The trial aims to see if having a specialized team, including vascular surgeons, can improve the outcomes for patients undergoing this type of surgery.

To be eligible for this trial, participants must be at least 18 years old and have a diagnosed retroperitoneal mass that needs surgical removal. They must also be scheduled for surgery that will involve the assistance of a vascular surgeon. If you join the study, you can expect to receive care from a team of experts and be monitored closely during your treatment. This trial is currently recruiting participants of all genders, and it’s important to understand that, while larger surgeries may carry some risks, the study aims to improve overall success and survival rates for patients with these tumors.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient diagnosed with a retroperitoneal mass involving the abdominal and/or pelvic vascular structures and requiring surgical removal
• • Planned surgical treatment with intra-operative assistance from the vascular surgeon
• • Obtaining informed consent
• • Age 18 years
• Exclusion Criteria:
• • -